Search

everythinglearnresearchcommunity

for

Search:↓

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Minoxidil helped bald patient regrow hair.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Certain mature cells in mouse lungs can turn back into stem cells to aid in tissue repair.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

TRH stimulates human hair growth and extends the hair growth phase.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

The gene p53 is crucial for removing damaged cells to allow for healthy tissue renewal.

Using neurohormones to control keratin can lead to new skin disease treatments.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Stress hormone CRF can cause hair loss by affecting hair growth cells and hormones.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.